NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Celgene Corporation


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Alexandria Real Estate Equities, Inc. Provides Update
2009 NOV 9 ... Other Alexandria client tenants at Mission Bay include such prestigious entities as Celgene Corporation, Merck & Co., Inc., Presidio Pharmaceuticals, Inc., Five Prime Therapeutics, Inc., Ion ...
Subject: Therapy
Price: $3.00
*
Big Pharma conclude M&A is not the new R&D
2009 NOV 16 ... Keywords: Life Sciences, Biotechnology Business, Biotechnology Company, Celgene Corporation, Pharmaceutical Business, Pharmaceutical Company, Pharmaceuticals, Therapy, Treatment. ...
Subject: Life Sciences
Price: $3.00
*
BioPharm America(TM) Unveils Preliminary Program Highlights
2009 AUG 31 ... Investing, Marketing, Technology, Biotechnology Business, Biotechnology Company, Celgene Corporation, Genentech Inc., Pfizer, Pharmaceutical Business, Pharmaceutical Company, ...
Subject: EBD Group
Price: $3.00
*
Celgene Corporation to Present at the JMP Securities Fourth Annual Healthcare Focus Conference
2009 OCT 12 ... Celgene Corporation (NASDAQ: CELG) announced its presentation at the JMP Securities Fourth Annual Healthcare ...
Subject: Celgene Corporation
Price: $3.00
*
Celgene Corporation to Present at the Oppenheimer & Co. Inc. 20th Annual Healthcare Conference
2009 NOV 9 ... Celgene Corporation (NASDAQ: CELG) announced its presentation at the Oppenheimer & Co. Inc. 20th Annual ...
Subject: Celgene Corporation
Price: $3.00
*
Celgene Corporation to Present at the UBS Global Life Sciences Conference
2009 SEP 28 ... Celgene Corporation (NASDAQ: CELG) announced its presentation at the UBS Global Life Sciences Conference on ...
Subject: Celgene Corporation
Price: $3.00
*
Celgene Reports Record Third Quarter 2009 Operating and Financial Results
2009 NOV 2 ... Celgene Corporation (NASDAQ:CELG): 2009 Third Quarter Financial Results Year-Over-Year: Non-GAAP Total ...
Subject: Celgene Corporation
Price: $3.00
*
Clinical Data Evaluating Amrubicin(R) as Potential Therapy for Patients with Small Cell Lung Cancer Presented at 13th World Conference on Lung Cancer
2009 AUG 18 ... Celgene Corporation (NASDAQ: CELG) announced the presentation of final results from two company-sponsored ...
Subject: Celgene Corporation
Price: $3.00
*
Critical Alerts for JPMorgan Chase, Monsanto, Celgene, VMWare, and Allergan Released by Seven Summits Research
2009 SEP 14 ... cover the following stocks: JPMorgan Chase & Co. (NYSE:JPM), Monsanto Co. (NYSE:MON), Celgene Corporation (NASDAQ:CELG), VMware, Inc. (NYSE:VMW), and Allergan Inc. (NYSE:AGN). In ...
Subject: Seven Summits Investment Research
Price: $3.00
*
Lawsuit Claims Celgene Corporation Misappropriated the Idea Behind its Multiple Myeloma Treatments
2009 SEP 7 ... Beth R. Jacobson (formerly Beth R. Wolmer) filed suit yesterday against Celgene Corporation (NASDAQ:CELG), under the claims of "misappropriation of an idea" and "unjust ...
Subject: Myeloma
Price: $3.00
*
Ligand Updates License Agreement with Exelixis
2009 NOV 16 ... Biotechnology Business, Biotechnology Company, Bristol-Myers Squibb Company Inc., Celgene Corporation, Cephalon, Clinical Trial Research, Clinical Trials, Dermatology, Drug Development, Drug ...
Subject: Ligand Pharmaceuticals Incorporated
Price: $3.00
*
More Than 200 Abstracts Evaluating Celgene Products across a Range of Indications to Be Presented at the 51st American Society of Hematology Meeting
2009 NOV 23 ... Celgene Corporation (NASDAQ: CELG) announced that clinical investigators from leading hematology research ...
Subject: Celgene Corporation
Price: $3.00
*
Multiple Myeloma Research Foundation's MMRF Fall Gala Raises More Than $1.8 Million to Advance Cancer Research
2009 NOV 9 ... Kathy Giusti, a multiple myeloma patient and Founder and CEO of the MMRF Celgene Corporation and Pepsico comprised the evening's Leadership Circle. MMRF Fall Gala Vice Chairs were ...
Subject: Multiple Myeloma Research Foundation MMRF
Price: $3.00
*
New Higher Dose of Focalin XR(R) Improves Control of ADHD Symptoms for Up to 12 Hours
2009 NOV 16 ... please visit http://www.novartis.com. Novartis Partnerships Celgene Corporation (Nasdaq: CELG) of Summit, New Jersey granted Novartis Pharma AG an exclusive worldwide ...
Subject: Pediatrics
Price: $3.00
*
PTC Therapeutics Announces Celgene Exercised Option to Drug Discovery Collaboration
2009 SEP 14 ... PTC Therapeutics, Inc. (PTC) announced that Celgene Corporation has exercised its option to collaborate on advancing drug discovery efforts on an ...
Subject: Biotechnology Business
Price: $3.00
*
Reports outline biotechnology business research from Celgene Corporation
2009 AUG 31 ... interleukin-2 expression in T cells," wrote Y.B. Xu and colleagues, Celgene Corporation. The researchers concluded: "These novel activities provide what we ...
Subject: Biotechnology Business
Price: $3.00
*
Switzerland Announces Winners of Significant Investment Projects for 2008
2009 NOV 2 ... Autodesk, CEMEX, Electronic Arts, Kyphon, Microsoft, Amgen, IBM, Stryker, VeriSign, Celgene, eBay, Google and P&G. Please see our website at www.locationswitzerland.com for copies ... Baxter International, Yahoo!, Alcon Corporation, AGCO, Medtronic and CSL Behring will receive Tell Awards for Switzerland's most ...
Subject: Switzerland Trade and Investment Promotion
Price: $3.00
*
Updated Data from Randomized Controlled Phase II Study Evaluating Oral Apremilast in Psoriatic Arthritis Demonstrates Sustained Response at Six Months
2009 NOV 2 ... Celgene Corporation (NASDAQ: CELG) announced that updated results of a phase II, multi-center, randomized, ...
Subject: Celgene Corporation
Price: $3.00
*
Updated NCCN Guidelines for AML Include Risk Stratification to Assist in Treatment Selection
2009 NOV 2 ... age alone. In the updated NCCN Guidelines, 5-azacytidine (Vidaza®, Celgene Corporation) and decitabine (Dacogen®, Eisai Inc.), have been added as low intensity treatment ...
Subject: Leukemia
Price: $3.00
*
WaferGen Adds Robert Coradini, Former President of J&J New Ventures, to Board of Directors
2009 NOV 9 ... addition to our Board, along with the recent appointment of Dr. Robert Hariri, CEO of Celgene Cellular Therapeutics, will significantly help us become a preferred R&D partner for ... Biosystems Ltd., Biotechnology Business, Biotechnology Company, ETHICON GmbH, Cordis Corporation, Angiology, Diagnostics This article was prepared by Biotech Business Week ...
Subject: WaferGen Biosystems, Inc.
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login